AbbVie Inc. stock rises Thursday, outperforms market

AbbVie Inc. stock rises Thursday, outperforms market

Shares of AbbVie Inc. ABBV, +0.47% inched 0.47% higher to $117.54 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, +0.20% rising 0.20% to 4,367.48 and the Dow Jones Industrial Average DJIA, +0.07% rising 0.07% to 34,823.35. This was the stock's third consecutive day of gains. AbbVie Inc. closed $0.81 short of its 52-week high ($118.35), which the company reached on July 12th. The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Pfizer Inc. PFE, +1.10% rose 1.10% to $41.47, Eli Lilly & Co. LLY, +0.51% rose 0.51% to $238.49, and AstraZeneca PLC ADR AZN, +0.33% rose 0.33% to $57.96. Trading volume (6.1 M) remained 207,911 below its 50-day average volume of 6.3 M. Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
More on: www.marketwatch.com